We have investigated by restriction fragment analysis genomic abnormalities involving the c-myc gene in DNA isolated from adenomas and hepatocellular carcinomas (HCCs). Adenomas and HCCs were induced by the “resistant hepatocyte” protocol in diethylnitrosamine-initiated male F344 rats. Southem- blot analysis of EcoRI-restricted DNA from normal liver, early and late adenomas, I2 weeks (EAs) and 30 weeks (Us) after initiation, and HCCs, showed 2 bands of 18 and 3.2 kb hybridizing with c-myc, in all tissues. c-rnyc amplification occurred in almost all HCCs, and in the majority of EAs and Us. These results were confirmed by dilution analysis. c-myc amplification was also seen in adenomas and HCCs by Southem analysis with Hindlll-restricted DNA, and in HCCs by differential PCR. c-myc mRNA increase occurred in all adenomas and HCCs, but it was higher in the lesions showing gene amplification. Moreover, a 13-kb DNA extraband, hybridizing with c-myc, was found in the Hindlll-restricted DNA from HCCs, but not in normal liver and adenomas, and a 7. I -kb extra band was present in EcoRI-digested DNA from one LA EcoRI-restricted DNA from some adenomas exhibited a decrease in intensity of the 18-kb fragment, and an increase in intensity of the 3.2-kb fragment. No alteration in banding pattern occurred in the B-actin gene in adenomas. These results provide evidence of amplification and some other rearrangements involving the c-myc gene, in pre-malignant and malignant liver lesions, induced by the RH protocol. and suaest a role of c-myc rearraniement inthe prog-mion of adenoias to malignancy.

c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model / Pascale, R. M.; DE MIGLIO, Maria Rosaria; Muroni, M. R.; Nufris, A.; Simile, M. M.; Daino, L.; Seddaiu, M. A.; Gaspa, L.; Deiana, L.; And, Feo. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 68:1(1996), pp. 136-142. [10.1002/(SICI)1097-0215(19960927)68:1<136::AID-IJC24>3.0.CO;2-8]

c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model

PASCALE, R. M.;DE MIGLIO, Maria Rosaria;MURONI, M. R.;SIMILE, M. M.;DAINO, L.;SEDDAIU, M. A.;
1996

Abstract

We have investigated by restriction fragment analysis genomic abnormalities involving the c-myc gene in DNA isolated from adenomas and hepatocellular carcinomas (HCCs). Adenomas and HCCs were induced by the “resistant hepatocyte” protocol in diethylnitrosamine-initiated male F344 rats. Southem- blot analysis of EcoRI-restricted DNA from normal liver, early and late adenomas, I2 weeks (EAs) and 30 weeks (Us) after initiation, and HCCs, showed 2 bands of 18 and 3.2 kb hybridizing with c-myc, in all tissues. c-rnyc amplification occurred in almost all HCCs, and in the majority of EAs and Us. These results were confirmed by dilution analysis. c-myc amplification was also seen in adenomas and HCCs by Southem analysis with Hindlll-restricted DNA, and in HCCs by differential PCR. c-myc mRNA increase occurred in all adenomas and HCCs, but it was higher in the lesions showing gene amplification. Moreover, a 13-kb DNA extraband, hybridizing with c-myc, was found in the Hindlll-restricted DNA from HCCs, but not in normal liver and adenomas, and a 7. I -kb extra band was present in EcoRI-digested DNA from one LA EcoRI-restricted DNA from some adenomas exhibited a decrease in intensity of the 18-kb fragment, and an increase in intensity of the 3.2-kb fragment. No alteration in banding pattern occurred in the B-actin gene in adenomas. These results provide evidence of amplification and some other rearrangements involving the c-myc gene, in pre-malignant and malignant liver lesions, induced by the RH protocol. and suaest a role of c-myc rearraniement inthe prog-mion of adenoias to malignancy.
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model / Pascale, R. M.; DE MIGLIO, Maria Rosaria; Muroni, M. R.; Nufris, A.; Simile, M. M.; Daino, L.; Seddaiu, M. A.; Gaspa, L.; Deiana, L.; And, Feo. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 68:1(1996), pp. 136-142. [10.1002/(SICI)1097-0215(19960927)68:1<136::AID-IJC24>3.0.CO;2-8]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11388/58770
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 28
social impact